公 司 名:北京义翘神州科技股份有限公司
所 在 地:北京市北京经济技术开发区科创十街18号院9号楼306室
服务电话(移):登录可见
服务电话(座):登录可见
在线交易:1626 笔
流行性感冒是一种常见的季节性可传染的呼吸道疾病,由流感病毒引起。接种流感疫苗是预防流行性感冒最有效的方法之一。由于流感病毒突变株较多,每年流行毒株存在差异,因此会根据最新分离出的毒株检测数据以及上一个季节流感疫苗的性能,每年都会选择3-4种不同的流感毒株作为疫苗株。
每年的疫苗株通常都包括甲型流感和乙型流感。根据流感病毒的两种表面抗原血凝素(HA)和神经氨酸酶(NA)的不同,甲型流感可以分成多种亚型,而乙型流感可以分成两种谱系,即Yamagata和Victoria。
为了支持流感的研究,义翘神州开发了一系列流感病毒重组抗原产品,涵盖从2015年至2022年的大部分疫苗株。这些产品既包括HA和NA蛋白,也包括一些核蛋白(NP)蛋白。如果您感兴趣的抗原(或菌株)不在当前列表中,您可以联系我们进行定制。
A/Victoria/2570/2019 (H1N1) | A/Cambodia/e0826360/2020 (H3N2) |
Egg-based (quadrivalent,trivalent) | Egg-based, Cell- or recombinant-base (quadrivalent, trivalent) |
HA: 40787-V08H, 40787-V08H1 | HA: 40789-V08H, 40789-V08H1 |
NA: 40785-V08B | NA: 40784-V08B |
NP: 40774-V08B | NP: 40778-V08B |
B/Washington/02/2019 | B/Phuket/3073/2013 |
Egg-based, Cell- or recombinant-base (quadrivalent, trivalent) | Egg-based, Cell- or recombinant-base (quadrivalent) |
HA: 40722-V08H | HA: 40498-V08B |
NA: 40790-V08B | NA: 40502-V07B |
NP: 40755-V08B | NP: 40500-V08B |
A/Wisconsin/588/2019(H1N1) |
Cell- or recombinant-base (quadrivalent, trivalent) |
HA: 40787-V08H, 40787-V08H1 |
NA: 40785-V08B |
NP: 40774-V08B |
A/Guangdong-Maonan/SWL1536/2019 (H1N1) | A/Hong Kong/2671/2019 (H3N2) |
Egg-based (quadrivalent, trivalent) | Egg-based (quadrivalent, trivalent) |
HA: 40717-V08H | HA: 40721-V08H |
NP: 40723-V08B | NP: 40753-V08B |
A/Hawaii/70/2019 (H1N1) | A/Hong Kong/45/2019 (H3N2) |
Cell- or recombinant-based (quadrivalent, trivalent) | Cell- or recombinant-based (quadrivalent, trivalent) |
HA: 40717-V08H | HA: 40765-V08H |
NP: 40724-V08B | NP: 40754-V08B |
B/Phuket/3073/2013 | B/Washington/02/2019 |
Egg-based,Cell- or recombinant-based (quadrivalent) | Egg-based,Cell- or recombinant-base (quadrivalent, trivalent) |
HA: 40498-V08B | HA: 40722-V08H |
NA: 40502-V07B | NP: 40755-V08B |
NP: 40500-V08B |
A/Brisbane/02/2018 (H1N1) | A/Kansas/14/2017 (H3N2) |
Egg-based(quadrivalent) | Egg-based(quadrivalent) |
HA: 40719-V08H | HA: 40720-V08H |
NP: 40776-V08B | NP: 40779-V08B |
B/Phuket/3073/2013 | B/Colorado/06/2017 |
Egg-based(quadrivalent) | Egg-based(quadrivalent); trivalent |
HA: 40502-V07B | HA: 40581-V08H |
NA: 40502-V07B | NP: 40782-V08B |
NP: 40500-V08B |
A/Michigan/45/2015 (H1N1) | A/Singapore/INFIMH-16-0019/2016 (H3N2) |
quadrivalent | quadrivalent |
HA: 40567-V08H1 | HA: 40580-V08H |
NA: 40568-V08B | NP: 40779-V08B |
NP: 40777-V08B |
B/Phuket/3073/2013 | B/Colorado/06/2017 |
quadrivalent | quadrivalent; trivalent |
HA: 40498-V08B | HA: 40581-V08H |
NA: 40502-V07B | NP: 40782-V08B |
NP: 40500-V08B |
A/Michigan/45/2015 (H1N1) | A/Hong Kong/4801/2014 (H3N2) |
trivalent | trivalent |
HA: 40567-V08H1 | HA: 40555-V08B |
NA: 40568-V08B | NA: 40569-V08B |
NP: 40777-V08B | NP: 40781-V08B |
B/Brisbane/60/2008 | B/Phuket/3073/2013 |
trivalent | quadrivalent |
HA: 40016-V08B | HA: 40498-V08B |
NA: 40203-VNAHC | NA: 40502-V07B |
NP: 40783-V08B | NP: 40500-V08B |
A/California/7/2009 (H1N1) | A/Hong Kong/4801/2014 (H3N2) |
trivalent | trivalent |
HA: 11085-V08B | HA: 40555-V08B |
NP: 40205-V08B | NA: 40569-V08B |
NP: 40781-V08B |
B/Brisbane/60/2008 | B/Phuket/3073/2013 |
trivalent | quadrivalent |
HA: 40016-V08B | HA: 40498-V08B |
NA: 40203-VNAHC | NA: 40502-V07B |
NP: 40783-V08B | NP: 40500-V08B |
A/California/7/2009 (H1N1) | A/Switzerland/9715293/2013 (H3N2) |
trivalent | trivalent |
HA: 11085-V08B | HA: 40497-V08B |
NP: 40205-V08B | NA: 40499-V08B |
B/Brisbane/60/2008 | B/Phuket/3073/2013 |
quadrivalent | trivalent |
HA: 40016-V08B | HA: 40498-V08B |
NA: 40203-VNAHC | NA: 40502-V07B |
NP: 40783-V08B | NP: 40500-V08B |